If needed, can make Covid-19 vaccine that works against new mutation in 6 weeks: BioNTech
Team Udayavani, Dec 22, 2020, 4:12 PM IST
BioNTech CEO Ugur Sahin on Tuesday said his company can make a new coronavirus vaccine that works against the mutated strain detected in the UK in six weeks in case the mutation is resistant to its current vaccine.
BioNTech has developed a Covid-19 vaccine with Pfizer. Sahin said that the proteins on the UK variant are 99% the same as on the prevailing strains, and therefore BioNTech has “scientific confidence” that its vaccine will be effective. He further said that it is “highly likely” that the vaccine will work against the new mutation.
We have scientific confidence that the vaccine might protect but we will only know it if the experiment is done… we will publish the data as soon as possible, he added
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
IPL 2021: RCB retains 12 players from IPL 2020
Eatery at Pune launches a contest, eat 4kg thali and win Royal Enfield Bullet
Ramalinga Reddy, Dhruva Narayana selected as KPCC Working Presidents
Related Articles More
K’taka COVID-19 update: 501 new cases, 665 discharges, 4 deaths on Jan 19
US couple celebrates 73rd wedding anniversary with vaccinations
47% of designated beneficiaries vaccinated on Jan 19 in Karnataka
K’taka COVID-19 update: 645 new cases, 807 discharges, 6 deaths on Jan 18
DK district receives 2nd batch of COVID-19 vaccine